AstraZeneca Purchases US Biologics Manufacturing Facility to Support Growing Pipeline

By: via Benzinga
AstraZeneca today added to its biologics manufacturing capability in the US with the purchase of a high-tech biologics bulk ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.